This episode explores questions in CLL with Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD during HOP Live 2024. Dr. Pemmaraju discusses three major unanswered questions for myeloproliferative neoplasm researchers. Dr. Usmani offers his take on treating smoldering myeloma and using MRD as a prognostic factor. At the 'HemOnc Pulse' Live meeting in Chicago, an expert panel explores unanswered questions in T-cell lymphoma management. The panel considered whether it’s time for new response criteria in myelofibrosis such as anemia improvement. Michael Bishop MD; Aaron Goodman, MD; and Rafael Fonseca, MD, discuss bispecifics in hematologic malignancies. An expert panel convened at the "HemOnc Pulse" Live meeting in Chicago explores unanswered questions in DLBCL management. The panel discussed ALL treatment, associated toxicities, and the possibility of a chemotherapy-free approach. The panel mainly discussed frontline tyrosine kinase inhibitors for the treatment of chronic phase CML. The panel discussed treatment options for Hodgkin lymphoma, maintenance therapy following autologous transplant, and more. The fellows discussed how to choose a career path, what makes a good mentor, and more. Live from Chicago, the panel discussed unanswered questions in CAR-T. Live in Chicago, this podcast episode features a panel discussion on unanswered questions in AML. Dr. Chadi Nabhan brings "The HemOnc Pulse" live to Chicago May 3-4.